/ESTA

ESTA Stock - Establishment Labs Holdings Inc.

Q: What is the analyst price target for ESTA?

Analyst price target information is not currently available for ESTA.

Q: What is ESTA's market cap?

Market capitalization information is not currently available for ESTA.

Healthcare|Medical - Devices|NASDAQ

$65.13-2.44%

$1.63 (-2.44%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+21.8%upside

Target: $79.33

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ESTA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.92

52W High$78.24

52W Low$26.56

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$166.03M	$165.15M	$161.70M	$126.68M	$84.68M
Gross Profit	$109.53M	$106.98M	$106.59M	$85.40M	$52.50M
Gross Margin	66.0%	64.8%	65.9%	67.4%	62.0%
Operating Income	$-49,987,000	$-65,026,000	$-39,658,000	$-25,140,000	$-27,916,000
Net Income	$-84,596,000	$-78,502,000	$-75,209,000	$-41,139,000	$-38,121,000
Net Margin	-51.0%	-47.5%	-46.5%	-32.5%	-45.0%
EPS	$-3.00	$-3.07	$-3.08	$-1.72	$-1.63

Company Overview

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Visit Website

Earnings History & Surprises

ESTA

Beat Rate

56%

Last 18 quarters

Avg Surprise

-13.3%

EPS vs Estimate

Beats / Misses

10/8

Last 12 quarters

Latest EPS

$-0.38

Q4 2025

EPS Surprise History

Q1 24

+13.2%

$-0.79vs$-0.91

Q2 24

+13.4%

$-0.58vs$-0.67

Q3 24

-21.6%

$-0.62vs$-0.51

Q4 24

+3.3%

$-0.59vs$-0.61

Q1 25

-53.1%

$-0.98vs$-0.64

Q2 25

+15.7%

$-0.70vs$-0.83

Q3 25

-5.6%

$-0.57vs$-0.54

Q4 25

+29.6%

$-0.38vs$-0.54

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 5, 2026	—	—	—	—
Q1 2026	Feb 25, 2026	$-0.22	—	—	—
Q4 2025	Nov 5, 2025	$-0.54	$-0.38	+29.6%	✓ BEAT
Q3 2025	Aug 7, 2025	$-0.54	$-0.57	-5.6%	✗ MISS
Q2 2025	May 7, 2025	$-0.83	$-0.70	+15.7%	✓ BEAT
Q1 2025	Feb 26, 2025	$-0.64	$-0.98	-53.1%	✗ MISS
Q4 2024	Nov 7, 2024	$-0.61	$-0.59	+3.3%	✓ BEAT
Q3 2024	Aug 6, 2024	$-0.51	$-0.62	-21.6%	✗ MISS
Q2 2024	May 8, 2024	$-0.67	$-0.58	+13.4%	✓ BEAT
Q1 2024	Feb 28, 2024	$-0.91	$-0.79	+13.2%	✓ BEAT
Q4 2023	Nov 7, 2023	$-0.80	$-1.12	-40.0%	✗ MISS
Q3 2023	Aug 8, 2023	$-0.72	$-0.65	+9.7%	✓ BEAT
Q2 2023	May 8, 2023	$-0.68	$-0.48	+29.4%	✓ BEAT
Q1 2023	Feb 27, 2023	$-0.68	$-0.55	+19.1%	✓ BEAT
Q4 2022	Nov 7, 2022	$-0.54	$-0.76	-40.7%	✗ MISS
Q3 2022	Aug 8, 2022	$-0.42	$-0.90	-114.3%	✗ MISS
Q2 2022	May 9, 2022	$-0.38	$-0.24	+36.8%	✓ BEAT
Q1 2022	Mar 1, 2022	$-0.33	$-0.60	-81.8%	✗ MISS
Q4 2021	Nov 9, 2021	$-0.35	$-0.61	-74.3%	✗ MISS
Q3 2021	Jul 29, 2021	$-0.28	$-0.22	+21.4%	✓ BEAT

Frequently Asked Questions about ESTA

What is ESTA's current stock price?

Establishment Labs Holdings Inc. (ESTA) is currently trading at $65.13 per share. The stock has moved -2.44% today.

What is the analyst price target for ESTA?

The average analyst price target for ESTA is $79.33, based on 1 analyst.

What sector is Establishment Labs Holdings Inc. in?

Establishment Labs Holdings Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.

What is ESTA's market cap?

Establishment Labs Holdings Inc. has a market capitalization of $1.89 billion, making it a small-cap company.

Does ESTA pay dividends?

No, Establishment Labs Holdings Inc. does not currently pay a dividend to shareholders.